Niagara Falls, NY, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positron Emission Tomography/Computed Tomography) imaging systems and clinical services, is pleased to announce the launch of its new Prime Rental Program, an all-inclusive rental offering of a Positron PET-CT system along with a comprehensive services package for a single monthly fee.
The Positron Prime Rental Program is designed to provide practices of all sizes with easy access to leading PET-CT technology and its numerous benefits for both patients and healthcare providers. Through this innovative monthly rental model, Positron offers financial and operational flexibility, eliminating the need for upfront capital expenditure. This all-encompassing package includes Positron’s PET-CT 64 Slice scanner, alongside clinical & technical support, technician training services and preventative maintenance ensuring optimal uptime and uninterrupted operations.
Key Benefits of the Prime Rental Program Include:
Eliminates CapEx: Practices can avoid large capital expenditures, preserving cash flow for other investments.
Flexible Financing: The monthly rental model helps practices manage cash flow while benefiting from superior imaging results achieved with PET-CT technology.
Comprehensive Services: The program includes full clinical and technical support, along with maintenance, and training ensuring seamless operations and dependable performance.
Future-Upgrades: Practices can take advantage of future upgrades, enhancing technology without additional CapEx expenses.
Predictable Monthly Expense: Stable fixed monthly rental payments for the life of the relationship.
Tax Advantages: Potential tax benefits through operational expense deductions.
“Our goal with the Prime Rental Program is to minimize barriers to entry and stimulate demand for PET-CT technology, making it accessible to all practices regardless of size, patient volumes or financial capabilities for upfront capital expenditures,” said Adel Abdullah, President of Positron Corporation. “There have been significant advancements in every aspect of nuclear cardiology that will drive the growth of the PET modality. We are confident that Positron’s NeuSight PET-CT, Services and Prime Rental Program can accelerate the adoption of PET, making it more appealing and advantageous than ever before for practices and their patients.”
